Ashkan Shoamanesh: Should Intracranial Hemorrhage Survivors with AFib Receive Anticoagulation?
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research and Care at McMaster University, shared on LinkedIn:
”Should intracranial hemorrhage (ICrH) survivors with atrial fibrillation receive anticoagulation?
If so: under which clinical circumstances?, after what time interval?, with what strategies to mitigate ICrH recurrence risk? and what is the level of supporting evidence?
These are common yet challenging questions in stroke practice, with many remaining unresolved.
We address them in detail in our recently published comprehensive review in the European Stroke Organisation Journal.”
Read the full article here.
Article: Oral Anticoagulation following intracranial haemorrhage in patients with atrial fibrillation
Authors: Ashkan Shoamanesh, Catharina JM Klijn, Kevin N Sheth, Roland Veltkamp, Else C Sandset, Charlotte Cordonnier, Rustam Al-Shahi Salman
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 17, 2026, 04:28Redefining Thromboprophylaxis in Multiple Myeloma: Early VTE Emerges as the Critical Therapeutic Challenge
-
Jul 16, 2026, 20:25Ilham Benzidia: Leaving ISTH 2026 With New Ideas and New Collaborations
-
Jul 16, 2026, 20:23Eman Hassan: A Fantastic Platelets and Megakaryocytes Session at ISTH 2026
-
Jul 16, 2026, 20:22Sankara Nelson Noah II: Investigating the Temporal Dynamics of Platelet – Leukocyte Interactions in Early Sepsis
-
Jul 16, 2026, 20:20Joseph Pierre Aboumsallem: Paris Certainly Delivered This Week, and Not Just Because of the Heat
-
Jul 16, 2026, 19:53Louise St. Germain Bannon: The End of Congress, the Beginning of New Collaborations
-
Jul 16, 2026, 19:18Steve Humphreys: Learning From the Leading Experts at ISTH 2026
-
Jul 16, 2026, 19:02Kellie Machlus: Where Science Meets Friendship at ISTH 2026
-
Jul 16, 2026, 18:51Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026